Immunother Limited today inaugurated their new Life Sciences Lab to accelerate their science through access to advanced technologies, services and training.
Online PR News – 12-April-2021 – SHENZHEN – Immunother Limited’s new Life Sciences Lab will support early stage research and development and also will feature advanced protein and cell analysis technologies including protein purification, drug discovery and cellular imaging technology.
Immunother Limited’s Co-Founder & Managing Director, Mr. Marcel Priest commented on the inauguration saying “We are extremely thrilled to be launching this new Life Sciences Lab facility which will help accelerate our research and development in the world of medicine. The new laboratory will include highly specialized scientific equipment.”
“The objective of this new Life Sciences Lab is to have the creativity, vision and scientific expertise to aid the transformation in medicine. With a team of medical experts at our disposal, the new facility will provide access to our sophisticated technology and help us as we research and develop new methods to accelerate and advance bio-therapeutics.”
About Us - Immunother Limited
Immunother Limited Company is a privately held Shenzhen-based preclinical stage biotechnology company focused on discovering and developing novel therapies for inflammatory diseases.
Immunother Limited Company creates lasting value through pioneering research in the field of immunology which leads to new product concepts, product development, and finally to the licensing of those products and associated intellectual property.